<DOC>
	<DOCNO>NCT00800280</DOCNO>
	<brief_summary>The purpose study estimate effect multiple dos cimetidine pharmacokinetics single dose PD 0332334 evaluate safety tolerability PD 0332334 co-administered cimetidine .</brief_summary>
	<brief_title>Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body</brief_title>
	<detailed_description>Detailed Description : Additional Study Purpose Details : Evaluate effect multiple dos cimetidine pharmacokinetics ( e.g. , elimination body ) single dose PD 0332334 . On February 18th 2009 , decision terminate development PD 0332334 communicate investigator study . The decision terminate study base safety concern .</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Cimetidine</mesh_term>
	<criteria>healthy male female adult Current history clinically significant medical illness Smokers Illicit drug use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>cimetidine , PD 0332334 , organic cation transporter , OCT2 , pharmacokinetics</keyword>
</DOC>